I don't necessarily disagree with you on the principle that it can be a nasty fight.
But, you look at patent protection mainly as an evil, anti-competitive, practice. In pharma IP protection is what matters most, and a company must do whatever it takes to protect their interests against other actors (generic drug producers which BTW are also $billion making businesses). In other words it's a normal aspect of competition.
Governments should set the rules that will benefit the greater good. Whether they do it well is yet another debate.
- Forums
- ASX - By Stock
- RAC
- Ann: Expanded Heart Protection Discovery for Zantrene
Ann: Expanded Heart Protection Discovery for Zantrene, page-176
-
- There are more pages in this discussion • 211 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.61 |
Change
0.165(11.5%) |
Mkt cap ! $273.4M |
Open | High | Low | Value | Volume |
$1.46 | $1.61 | $1.46 | $245.3K | 161.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 229 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.63 | 1226 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 229 | 1.570 |
1 | 40000 | 1.560 |
1 | 533 | 1.530 |
1 | 4000 | 1.520 |
1 | 6000 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.630 | 1226 | 1 |
1.640 | 12136 | 1 |
1.650 | 12920 | 2 |
1.690 | 585 | 1 |
1.750 | 14309 | 3 |
Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |